Skip to content

13F-HR filed by JW Asset Management, LLC

JW Asset Management, LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-12, with 56 holding rows worth $276,080,000.

Accession
0001420506-15-000588
Filed
2015-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2015

A holdings report, 56 entries on the cover page, a total value of $276,080,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $276,080,000 with VALUE read as thousands by filing date, 13F file number 028-16404. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EAGLE PHARMACEUTICALS INC269796108COM848,709$62,830,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock52,080$24,224,000thousands by filing date
CONCORDIA HEALTHCARE CORP206519100COM557,500$23,727,000thousands by filing date
Netflix, Inc64110L106COM217,484$22,457,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS773,899$15,339,000thousands by filing date
BLACKSTONE GROUP LP09253U108COM UNIT LTD414,593$13,130,000thousands by filing date
ALLERGAN PLCG0177J108SHS42,189$11,467,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK388,346$11,052,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON569,819$9,294,000thousands by filing date
BUFFALO WILD WINGS INC119848109COMMON STOCK31,180$6,031,000thousands by filing date
DEPOMED INC249908104COM315,236$5,942,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock36,186$5,691,000thousands by filing date
JUNIPER PHARMACEUTICALS INC COM48203L107Stock481,459$5,672,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM33,424$5,227,000thousands by filing date
META PLATFORMS INC CL A30303M102COM54,776$4,924,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM57,925$4,343,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock32,559$4,324,000thousands by filing date
Amazon.com, Inc023135106COM8,339$4,269,000thousands by filing date
QLT INC746927102COMMON STOCK1,592,993$4,237,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM73,586$3,204,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW36,174$3,098,000thousands by filing date
TARO PHARMACEUTICAL INDS LTDM8737E108SHS20,312$2,902,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM63,373$2,231,000thousands by filing date
Starbucks Corporation855244109COM32,690$1,858,000thousands by filing date
CHIPOTLEMEXICANGRILLI169656105STOK2,447$1,762,000thousands by filing date
SAGENT PHARMACEUTICALS INC786692103COM106,630$1,635,000thousands by filing date
CAMBREX CORP132011107COM40,573$1,610,000thousands by filing date
WINGSTOP INC COM974155103Stock62,057$1,488,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM35,864$1,417,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO6,507$1,335,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM31,844$1,322,000thousands by filing date
ENDO INTL PLCG30401106SHS13,192$914,000thousands by filing date
Mallinckrodt PlcG5785G107SHS12,766$816,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM71,377$805,000thousands by filing date
AKORN INC009728106COM26,506$756,000thousands by filing date
SHAKE SHACK INC819047101CL A14,548$690,000thousands by filing date
IGI LABORATORIES INC449575109COM90,720$593,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM30,140$505,000thousands by filing date
RETROPHIN INC761299106COM24,147$489,000thousands by filing date
DIGIRAD CORP253827109COM110,257$412,000thousands by filing date
PAPA MURPHYS HLDGS INC698814100COM20,724$304,000thousands by filing date
PETMED EXPRESS INC716382106COM18,702$301,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM7,974$256,000thousands by filing date
ANTARES PHARMA INC036642106COM142,198$242,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM67,009$212,000thousands by filing date
XENOPORT INC98411C100COM50,000$174,000thousands by filing date
MEDICAL TRANSCRIPTION BLG CO58464J105COM63,771$115,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM591$98,000thousands by filing date
GERON CORP374163103COM30,000$83,000thousands by filing date
CTI BIOPHARMA CORP COM NEW12648L106Stock52,271$76,000thousands by filing date
CUMBERLAND PHARMACEUTICALS I230770109COM10,939$63,000thousands by filing date
SECOND SIGHT MED PRODS INC81362J100COM8,500$50,000thousands by filing date
ROCKWELL MED INC774374102COM4,200$32,000thousands by filing date
UNIQURE NVN90064101SHS1,400$29,000thousands by filing date
BIOTA PHARMACEUTIALS INC090694100COM8,611$17,000thousands by filing date
NANOSPHERE INC COM NEW63009F204Stock3,451$6,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-15-000588this filing2015-11-12acceptance time not in the bulk data set